| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.801 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.741 | |
| regulation of cell activation | GO:0050865 | 289 | 0.562 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.545 | |
| immune effector process | GO:0002252 | 321 | 0.544 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.540 | |
| positive regulation of t cell costimulation | GO:2000525 | 2 | 0.464 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.407 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.398 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.352 | |
| positive regulation of t cell receptor signaling pathway | GO:0050862 | 4 | 0.322 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.300 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.296 | |
| t cell differentiation | GO:0030217 | 174 | 0.286 | |
| negative t cell selection | GO:0043383 | 13 | 0.284 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.282 | |
| regulation of lymphocyte anergy | GO:0002911 | 4 | 0.272 | |
| adaptive immune response | GO:0002250 | 155 | 0.271 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.257 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.254 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.243 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.240 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.240 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.237 | |
| natural killer cell inhibitory signaling pathway | GO:0002769 | 2 | 0.234 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.232 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.225 | |
| t cell activation | GO:0042110 | 289 | 0.225 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.214 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.204 | |
| regulation of t cell anergy | GO:0002667 | 4 | 0.203 | |
| negative thymic t cell selection | GO:0045060 | 12 | 0.195 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.192 | |
| positive t cell selection | GO:0043368 | 23 | 0.191 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.188 | |
| thymic t cell selection | GO:0045061 | 22 | 0.185 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.184 | |
| chemokine mediated signaling pathway | GO:0070098 | 17 | 0.183 | |
| amine metabolic process | GO:0009308 | 45 | 0.181 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.180 | |
| cytokine production | GO:0001816 | 319 | 0.178 | Human |
| regulation of monocyte extravasation | GO:2000437 | 2 | 0.175 | |
| t cell costimulation | GO:0031295 | 14 | 0.172 | |
| endomembrane system organization | GO:0010256 | 147 | 0.172 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.170 | |
| positive regulation of lymphocyte anergy | GO:0002913 | 4 | 0.169 | |
| hematopoietic stem cell migration | GO:0035701 | 1 | 0.164 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.163 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.161 | |
| t cell proliferation | GO:0042098 | 120 | 0.160 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.160 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.153 | |
| helper t cell chemotaxis | GO:0035704 | 1 | 0.152 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.151 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.151 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.151 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.146 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.145 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.145 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.145 | Human |
| regulation of mapk cascade | GO:0043408 | 248 | 0.145 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.142 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.142 | |
| regulation of t cell extravasation | GO:2000407 | 3 | 0.140 | |
| jnk cascade | GO:0007254 | 72 | 0.139 | |
| antigen processing and presentation of peptide antigen via mhc class ii | GO:0002495 | 17 | 0.134 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.134 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.132 | |
| alpha beta t cell proliferation | GO:0046633 | 21 | 0.129 | |
| cd8 positive alpha beta t cell extravasation | GO:0035697 | 3 | 0.129 | |
| muscle tissue development | GO:0060537 | 308 | 0.128 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.128 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.125 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.123 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.123 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.122 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.121 | |
| regulation of protein localization | GO:0032880 | 231 | 0.117 | Human |
| negative regulation of molecular function | GO:0044092 | 258 | 0.117 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.117 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.116 | |
| eosinophil mediated immunity | GO:0002447 | 1 | 0.116 | |
| innate immune response activating cell surface receptor signaling pathway | GO:0002220 | 4 | 0.115 | |
| regulation of secretion | GO:0051046 | 274 | 0.115 | Human |
| response to interferon gamma | GO:0034341 | 34 | 0.114 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.113 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.113 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.112 | |
| chemotaxis | GO:0006935 | 247 | 0.112 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.111 | |
| exocytosis | GO:0006887 | 121 | 0.110 | |
| actin filament organization | GO:0007015 | 113 | 0.110 | |
| cation transport | GO:0006812 | 399 | 0.110 | |
| negative regulation of epidermal growth factor activated receptor activity | GO:0007175 | 3 | 0.108 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.108 | |
| immune complex clearance | GO:0002434 | 2 | 0.107 | |
| positive regulation of immunological synapse formation | GO:2000522 | 1 | 0.106 | |
| positive regulation of cd8 positive alpha beta t cell extravasation | GO:2000451 | 2 | 0.105 | |
| regulation of eosinophil degranulation | GO:0043309 | 1 | 0.105 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.103 | |
| microglial cell activation involved in immune response | GO:0002282 | 1 | 0.103 | |
| eosinophil activation involved in immune response | GO:0002278 | 1 | 0.103 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.102 | |
| positive regulation of hematopoietic stem cell migration | GO:2000473 | 1 | 0.102 | |
| regulation of dendritic cell chemotaxis | GO:2000508 | 1 | 0.101 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.101 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.100 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.099 | |
| natural killer cell mediated cytotoxicity | GO:0042267 | 29 | 0.099 | |
| gliogenesis | GO:0042063 | 141 | 0.099 | |
| regulation of cell migration | GO:0030334 | 219 | 0.099 | |
| t cell extravasation | GO:0072683 | 4 | 0.098 | |
| monocyte extravasation | GO:0035696 | 2 | 0.098 | |
| cation homeostasis | GO:0055080 | 212 | 0.097 | |
| angiogenesis | GO:0001525 | 201 | 0.097 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.096 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.096 | |
| sensory perception | GO:0007600 | 245 | 0.096 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.096 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.095 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.095 | |
| activation of immune response | GO:0002253 | 138 | 0.094 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.093 | |
| positive regulation of t cell anergy | GO:0002669 | 4 | 0.092 | |
| inflammatory response | GO:0006954 | 244 | 0.092 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.091 | |
| interleukin 2 production | GO:0032623 | 33 | 0.090 | |
| t cell selection | GO:0045058 | 34 | 0.090 | |
| regulation of immune complex clearance by monocytes and macrophages | GO:0090264 | 2 | 0.090 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.090 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.090 | |
| action potential | GO:0001508 | 78 | 0.090 | |
| blood circulation | GO:0008015 | 195 | 0.090 | |
| sensory perception of pain | GO:0019233 | 47 | 0.089 | |
| membrane organization | GO:0061024 | 245 | 0.088 | |
| t cell anergy | GO:0002870 | 4 | 0.088 | |
| negative regulation of eosinophil degranulation | GO:0043310 | 1 | 0.088 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 40 | 0.086 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.085 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.084 | |
| immune complex clearance by monocytes and macrophages | GO:0002436 | 2 | 0.084 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.083 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.082 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.082 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.082 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.081 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.081 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.080 | |
| muscle cell development | GO:0055001 | 133 | 0.080 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.080 | |
| lymphocyte anergy | GO:0002249 | 4 | 0.079 | |
| muscle contraction | GO:0006936 | 101 | 0.078 | |
| mapk cascade | GO:0000165 | 281 | 0.077 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.077 | |
| regulation of antigen receptor mediated signaling pathway | GO:0050854 | 29 | 0.075 | |
| regulation of t cell costimulation | GO:2000523 | 2 | 0.074 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.071 | |
| positive regulation of alpha beta t cell activation | GO:0046635 | 39 | 0.071 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.071 | |
| eosinophil activation | GO:0043307 | 1 | 0.070 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.070 | |
| myeloid cell activation involved in immune response | GO:0002275 | 34 | 0.070 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.069 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.069 | |
| regulation of neutrophil chemotaxis | GO:0090022 | 14 | 0.069 | |
| innate immune response | GO:0045087 | 157 | 0.068 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.068 | Human |
| neutrophil migration | GO:1990266 | 37 | 0.068 | |
| regulation of interleukin 2 production | GO:0032663 | 28 | 0.068 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.067 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.067 | |
| positive regulation of dendritic cell chemotaxis | GO:2000510 | 1 | 0.067 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.067 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.067 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.066 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.066 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.065 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.065 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.063 | |
| stimulatory c type lectin receptor signaling pathway | GO:0002223 | 2 | 0.062 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.062 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.062 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.061 | Human |
| leukocyte migration | GO:0050900 | 124 | 0.061 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.061 | |
| maintenance of location | GO:0051235 | 89 | 0.061 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.061 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.061 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.061 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.060 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.060 | |
| natural killer cell mediated immunity | GO:0002228 | 29 | 0.060 | |
| circulatory system process | GO:0003013 | 197 | 0.059 | |
| protein localization to membrane | GO:0072657 | 108 | 0.058 | |
| organelle assembly | GO:0070925 | 177 | 0.058 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.057 | |
| lymphocyte costimulation | GO:0031294 | 15 | 0.056 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.056 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.055 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.055 | |
| plasma membrane organization | GO:0007009 | 90 | 0.055 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.055 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.055 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.054 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.054 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.054 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.054 | |
| axonogenesis | GO:0007409 | 274 | 0.053 | |
| positive regulation of monocyte extravasation | GO:2000439 | 1 | 0.053 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.052 | |
| regulation of cd8 positive alpha beta t cell extravasation | GO:2000449 | 3 | 0.052 | |
| t helper 1 type immune response | GO:0042088 | 25 | 0.052 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.051 | |
| regulation of t cell receptor signaling pathway | GO:0050856 | 21 | 0.051 | |
| striated muscle cell development | GO:0055002 | 125 | 0.051 | |
| dendritic cell chemotaxis | GO:0002407 | 7 | 0.050 | |
| cellular homeostasis | GO:0019725 | 240 | 0.050 | |
| organelle fission | GO:0048285 | 170 | 0.050 | |
| positive thymic t cell selection | GO:0045059 | 13 | 0.050 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.050 | |
| regulation of cell motility | GO:2000145 | 236 | 0.049 | |
| regulation of natural killer cell activation | GO:0032814 | 22 | 0.048 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.048 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.047 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.047 | |
| cellular response to lipid | GO:0071396 | 145 | 0.047 | |
| forebrain development | GO:0030900 | 302 | 0.047 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.047 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.047 | |
| positive regulation of alpha beta t cell proliferation | GO:0046641 | 12 | 0.046 | |
| positive regulation of t cell proliferation | GO:0042102 | 52 | 0.046 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.046 | Human |
| positive regulation of granulocyte chemotaxis | GO:0071624 | 12 | 0.046 | |
| natural killer cell activation | GO:0030101 | 44 | 0.046 | |
| negative regulation of macrophage apoptotic process | GO:2000110 | 3 | 0.046 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.045 | |
| cytokine secretion | GO:0050663 | 72 | 0.045 | Human |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.044 | |
| cellular extravasation | GO:0045123 | 17 | 0.044 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.044 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.044 | |
| regulation of cell division | GO:0051302 | 76 | 0.044 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.044 | |
| blastocyst growth | GO:0001832 | 23 | 0.044 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.044 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.044 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.044 | |
| regulation of defense response | GO:0031347 | 233 | 0.043 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.043 | |
| cell killing | GO:0001906 | 67 | 0.043 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.043 | |
| cell chemotaxis | GO:0060326 | 81 | 0.043 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.043 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.043 | |
| regulation of system process | GO:0044057 | 200 | 0.042 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.042 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.042 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.042 | |
| oxidation reduction process | GO:0055114 | 342 | 0.042 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.042 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.042 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.041 | |
| organelle localization | GO:0051640 | 179 | 0.041 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.041 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.040 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.040 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.040 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.040 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.040 | |
| regulation of alpha beta t cell proliferation | GO:0046640 | 18 | 0.040 | |
| regulation of ion transport | GO:0043269 | 215 | 0.040 | |
| gland development | GO:0048732 | 330 | 0.040 | |
| antigen processing and presentation of exogenous peptide antigen via mhc class ii | GO:0019886 | 14 | 0.040 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.039 | |
| leukocyte degranulation | GO:0043299 | 27 | 0.039 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.039 | Human |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.039 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.039 | |
| type 2 immune response | GO:0042092 | 23 | 0.039 | |
| regulation of b cell proliferation | GO:0030888 | 39 | 0.039 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.038 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.038 | |
| positive regulation of t cell extravasation | GO:2000409 | 2 | 0.038 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.038 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.038 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.038 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.038 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.038 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.038 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.038 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.037 | |
| myosin filament assembly | GO:0031034 | 2 | 0.037 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.037 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.037 | |
| defense response to other organism | GO:0098542 | 197 | 0.037 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.037 | |
| tolerance induction | GO:0002507 | 14 | 0.036 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.036 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.036 | |
| antigen processing and presentation of exogenous peptide antigen | GO:0002478 | 21 | 0.036 | |
| ossification | GO:0001503 | 216 | 0.036 | |
| eosinophil degranulation | GO:0043308 | 1 | 0.036 | |
| regulation of tube size | GO:0035150 | 57 | 0.035 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.035 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.035 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.035 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.035 | |
| protein catabolic process | GO:0030163 | 221 | 0.035 | |
| regulation of interleukin 2 biosynthetic process | GO:0045076 | 13 | 0.035 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.035 | |
| cell recognition | GO:0008037 | 83 | 0.035 | |
| inner cell mass cell proliferation | GO:0001833 | 15 | 0.035 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.035 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.035 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.035 | |
| positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation | GO:2000526 | 1 | 0.035 | |
| heart process | GO:0003015 | 94 | 0.035 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.034 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.034 | Human |
| myeloid dendritic cell chemotaxis | GO:0002408 | 2 | 0.034 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.034 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.034 | Human |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.034 | |
| nuclear transport | GO:0051169 | 139 | 0.034 | |
| positive regulation of immune complex clearance by monocytes and macrophages | GO:0090265 | 2 | 0.034 | |
| regulation of cell killing | GO:0031341 | 40 | 0.034 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.034 | |
| telencephalon development | GO:0021537 | 186 | 0.034 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.034 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.033 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.033 | |
| microtubule based process | GO:0007017 | 236 | 0.033 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.033 | |
| epithelial cell development | GO:0002064 | 159 | 0.033 | |
| glial cell differentiation | GO:0010001 | 131 | 0.033 | |
| negative regulation of leukocyte apoptotic process | GO:2000107 | 31 | 0.033 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.033 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.032 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.032 | |
| muscle system process | GO:0003012 | 141 | 0.032 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.032 | |
| antigen processing and presentation of exogenous antigen | GO:0019884 | 26 | 0.032 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.032 | Human |
| neuronal action potential | GO:0019228 | 54 | 0.032 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.032 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.032 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.032 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.032 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.032 | Human |
| single organism cell adhesion | GO:0098602 | 156 | 0.032 | Human |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.032 | |
| lipid homeostasis | GO:0055088 | 63 | 0.032 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.031 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.031 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.031 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.031 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.031 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.031 | |
| cell adhesion | GO:0007155 | 329 | 0.031 | Human |
| positive regulation of t helper 1 cell cytokine production | GO:2000556 | 1 | 0.031 | |
| myotube differentiation | GO:0014902 | 105 | 0.031 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.031 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.031 | |
| regulation of natural killer cell mediated cytotoxicity | GO:0042269 | 19 | 0.030 | |
| microglial cell activation | GO:0001774 | 3 | 0.030 | |
| inflammatory response to antigenic stimulus | GO:0002437 | 30 | 0.030 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.030 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.030 | |
| leukocyte cell cell adhesion | GO:0007159 | 14 | 0.030 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 28 | 0.030 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.030 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.030 | |
| protein maturation | GO:0051604 | 176 | 0.029 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.029 | |
| muscle fiber development | GO:0048747 | 76 | 0.029 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.029 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.029 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.029 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.029 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.029 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.029 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.028 | |
| protein processing | GO:0016485 | 163 | 0.028 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.028 | |
| t cell migration | GO:0072678 | 19 | 0.028 | |
| calcium ion transport | GO:0006816 | 159 | 0.028 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.028 | |
| endocrine system development | GO:0035270 | 98 | 0.028 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.028 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.028 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.028 | |
| regulation of regulated secretory pathway | GO:1903305 | 20 | 0.028 | |
| membrane depolarization | GO:0051899 | 64 | 0.027 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.027 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.027 | |
| regulation of t helper 1 type immune response | GO:0002825 | 17 | 0.027 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.027 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.027 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.027 | |
| microglia differentiation | GO:0014004 | 2 | 0.027 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.027 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.027 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.027 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.027 | |
| positive regulation of gliogenesis | GO:0014015 | 27 | 0.026 | |
| developmental cell growth | GO:0048588 | 84 | 0.026 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.026 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.026 | |
| interferon gamma production | GO:0032609 | 67 | 0.026 | Human |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.026 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.026 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.026 | |
| cell fate commitment | GO:0045165 | 210 | 0.026 | |
| mast cell activation | GO:0045576 | 27 | 0.026 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.026 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.026 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.026 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.026 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.026 | Human |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.025 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.025 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.025 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.025 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.025 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.025 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.025 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.025 | |
| protein polymerization | GO:0051258 | 57 | 0.025 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.025 | Human |
| regulation of inflammatory response to antigenic stimulus | GO:0002861 | 21 | 0.025 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.025 | |
| sphingosine 1 phosphate signaling pathway | GO:0003376 | 3 | 0.025 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.024 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.024 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.024 | |
| positive regulation of natural killer cell mediated immunity | GO:0002717 | 16 | 0.024 | |
| regulation of homotypic cell cell adhesion | GO:0034110 | 13 | 0.024 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.024 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.024 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.024 | |
| camp metabolic process | GO:0046058 | 40 | 0.024 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.024 | |
| renal sodium excretion | GO:0035812 | 3 | 0.024 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 17 | 0.024 | |
| granulocyte migration | GO:0097530 | 43 | 0.024 | |
| interleukin 1 production | GO:0032612 | 31 | 0.024 | |
| mast cell activation involved in immune response | GO:0002279 | 20 | 0.024 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.024 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.024 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.024 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.024 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.023 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.023 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.023 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.023 | |
| positive regulation of tor signaling | GO:0032008 | 3 | 0.023 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.023 | |
| negative regulation of exocytosis | GO:0045920 | 12 | 0.023 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.023 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.023 | |
| regulated secretory pathway | GO:0045055 | 32 | 0.023 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.023 | |
| interleukin 1 beta secretion | GO:0050702 | 16 | 0.023 | |
| monosaccharide transport | GO:0015749 | 58 | 0.023 | |
| interleukin 12 production | GO:0032615 | 32 | 0.023 | |
| positive regulation of antigen receptor mediated signaling pathway | GO:0050857 | 9 | 0.022 | |
| axon guidance | GO:0007411 | 141 | 0.022 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.022 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.022 | |
| positive regulation of interleukin 2 biosynthetic process | GO:0045086 | 8 | 0.022 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.022 | |
| interleukin 4 production | GO:0032633 | 24 | 0.022 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.022 | |
| immunoglobulin production | GO:0002377 | 73 | 0.022 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.022 | |
| synaptic transmission | GO:0007268 | 329 | 0.022 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.022 | |
| regulation of protein binding | GO:0043393 | 60 | 0.022 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.022 | |
| mast cell degranulation | GO:0043303 | 19 | 0.021 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.021 | |
| developmental maturation | GO:0021700 | 193 | 0.021 | |
| tolerance induction to self antigen | GO:0002513 | 4 | 0.021 | |
| ear development | GO:0043583 | 200 | 0.021 | |
| amide transport | GO:0042886 | 138 | 0.021 | |
| regulation of antigen processing and presentation | GO:0002577 | 10 | 0.021 | |
| cell growth | GO:0016049 | 130 | 0.021 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.021 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.021 | |
| regulation of neutrophil migration | GO:1902622 | 14 | 0.021 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.021 | |
